On Sept. 3 20+ organizations — including TAG — signed this Infectious Diseases Society of America’s (IDSA) joint statement calling for the resignation of Sec. Robert F. Kennedy Jr. The letter outlines the many ways Kennedy’s “agenda” is meant to undermine science and public health.
A listing of clinical trials and observational studies related to the research effort to cure HIV infection, mainly derived from the clinicaltrials.gov online registry.
Pipeline Report provides an overview of research and provides an overview of research and development of innovations for diagnosing, preventing, treating, and curing HIV, hepatitis C virus (HCV), and tuberculosis (TB).
Save the Date: Monday, October 20, 2025 , when our Research in Action Awards return this fall! We'll honor some of the most brilliant activists, scientists, and leaders in the fight to end HIV, tuberculosis (TB), and hepatitis C (HCV). Get your tickets now!
The current administration’s Executive Order on Ending Crime and Disorder on America’s streets is yet another direct attack on science and basic human rights.
The Trump Administration plan to end PEPFAR (the President's Emergency Plan for AIDS Relief) was leaked yesterday to the New York Times which had damning information about Secretary Rubio proposing a swift end to the program.
TAG was among thirteen organizations that cosponsored this Congressional briefing held on July 9, 2025. Briefing materials and presentations are available for download.
TAG's Senior TB Project Associate, Erin McConnell, created this 'zine about TAG for Pride 2025. It's about fighting back, and goes over current threats, action items, and action steps on how to show up.
June 2025 Media coverage: Breakthrough in search for HIV cure leaves researchers ‘overwhelmed’ - Kat Lay, The Guardian, June 5, 2025 Major breakthrough in battle for HIV cure ‘previously thought impossible’ - Athena Stavrou, Independent, June 5, 2025 Used in…
On Friday May 30, it was reported that National Institutes of Health (NIH) leadership has unilaterally terminated funding for HIV vaccine research consortia that were making significant progress toward solving the stern challenge of inducing protective broadly neutralizing antibodies against the virus.